UVM medical students are nothing if not multi-faceted and often use their vast and varied skill sets, talents, previous education, and work experiences to undertake groundbreaking projects and research in addition to their studies. Following in the footsteps of designMED Student Interest Group (SIG) founders Al Marchese '19, Lillian Chang, MD'17, and Anna Lidofsky '20, are Jhaimy Fernandez '21, Collin Anderson '21, Cari Carpenter '21, and Jenny Holland '21. The students are next in a growing group of #UVMFutureDocs who are combining their passion for medicine with an interest in innovation to positively impact and improve healthcare systems and technologies within the state of Vermont and beyond.

An evaluation of Vermont’s Hub and Spoke system of care led by University of Vermont Research Professor of Psychiatry Richard Rawson, Ph.D., shows that people in treatment for opioid addiction reported a 96 percent decrease in opioid use and a 100 percent drop in overdose incidences.

The Centers for Disease Control (CDC) has recently raised concerns about the effects of prescribed attention deficit hyperactivity disorder (ADHD) medication on unborn children. David Jones, M.D., director of the University of Vermont Medical Center Fetal Diagnostic Center, explains that while there is not much research on this topic, the risk of taking ADHD medication for women considering pregnancy is low.